The Psychedelic Report

In this episode of The Psychedelic Report, Dr. Dave Rabin welcomes renowned experts James Fadiman, PhD, and Jordan Gruber, JD, for a compelling conversation on the science and health significance of microdosing. Together, they explore the historical roots of psychedelics in America and their resurgence in modern medicine, shedding light on how these once-stigmatized substances are now being reexamined for their therapeutic potential.Gain a deeper understanding of what microdosing is, how it works in the brain and body, and the optimal protocols for safe and effective use. This discussion highlights the role of microdosing in enhancing neuroplasticity, reducing inflammation, and supporting mental health—especially for those grappling with treatment-resistant depression. With a mix of scientific insight, real-world experiences, and emerging research, this episode offers valuable takeaways for both newcomers and seasoned explorers of psychedelics.Microdosing for Health, Healing, and Enhanced Performance: http://MicrodosingBook.comTo dive even deeper, check out Your Symphony of Selves by Fadiman and Gruber, and check out our previous discussion on the TPR about microdosing and multiple personalities.Published Microdosing book related interviews and podcasts:https://www.microdosingbook.com/eventsWeb: https://thepsychedelic.reportTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

Psychedelic whole plant medicines have been used for thousands of years, yet there is very little modern research surrounding them. Despite this, various plants have been used to heal and transform our mental states, and according to some beliefs, as a way to open the heart and spirit, and even treat mental and physical illnesses. In this episode, Dr. Dave Rabin is sitting down with Stephanie Wang, CEO of KA! Empathogenics, to explore the history, uses, and potential mental health benefits of Kanna. Kanna is a fully legal and biochemically fascinating plant originating in South Africa. Together, they discuss the potential to enhance resilience, elevate mood, and promote emotional healing. How does it compare to MDMA? What can we learn from traditional plant wisdom? Join us as we dive into the evolving science and culture of psychedelics, revealing new pathways to well-being.Instagram: https://www.instagram.com/stephaniewang5d Web: https://kaempathogenics.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabin Web: https://www.drdave.io/

In this episode, Dr. Dave Rabin sits down with Jamie Wheal, bestselling author of Stealing Fire, and celebrated author of Recapture the Rapture, to explore the evolving role of psychedelics in society, from their historical significance in the 1960s counterculture to their emerging therapeutic applications today. They deep dive into consciousness, psychedelics, the concept of ‘rapture', the neuroscience of courage, and insights from Eric Kandel on how evolutionary learning mechanisms shape all decision-making. Examining the contrast between ancient plant medicine traditions and modern high-potency psychedelics, they highlight the challenges of integration, the risks of dependency, and the importance of preparation and support in therapeutic settings. They also address the commodification of psychedelics, the necessity of a sacramental approach, and the deeper spiritual and communal significance of these substances. Ultimately, they emphasize self-discovery, the acceptance of uncertainty, and the requirement for unity and responsible engagement with psychedelics to foster healing and collective transformation. Article: https://www.nytimes.com/2025/02/04/health/fda-mdma-psychedelic-therapy-psymposia.htmlBook: https://www.recapturetherapture.com/Instagram: https://www.instagram.com/jamiewheal/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/The Immortality Key by Brian Muraresku: https://brianmuraresku.com/

In this episode, Dr. Dave Rabin engages in a thought-provoking conversation with Skippy Mesirow. They delve into the evolving landscape of psychedelic medicine, discussing recent setbacks in the FDA's decision regarding MDMA-assisted therapy and the implications for the broader psychedelic community. Skippy shares his journey as a facilitator in the psychedelic space, offering insights from his work in Colorado's movement and innovative approaches in Aspen. Together, they discuss the vital role of community, compassion, and collaboration in advancing therapies, reflect on the healing and creative energy of Burning Man, and emphasize the importance of unity among advocates for decriminalization and legalization. Tune in for an inspiring call to action and valuable insights from two dedicated leaders in the field.Instagram: https://www.instagram.com/skippymesirow/Web: https://www.electedleaderscollective.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

What if true healing involves more than just the physical body? Join Dr. Dave Rabin in an inspiring conversation with filmmaker and author Kelly Gores, where they explore the intricate connection between mind, body, and spirit through the transformative potential of psychedelics, spirituality, and self-awareness. They delve into the field of epigenetics, explaining how our environment and experiences can turn genes on and off, directly impacting health outcomes. With powerful stories like Anita Morjani's near-death experience, Kelly illustrates how a change in perception can open pathways to profound healing and connection to our true selves.This episode also covers the “illusion of separation” that often leads to loneliness and fear, and how psychedelics can help dissolve this barrier, reconnecting us to a sense of universal love and oneness. Kelly shares her own practices of intention-setting and gratitude as transformative tools, showing how each of us holds the power to shape our reality. Tune in to uncover how embracing a holistic approach to healing can unlock resilience, empower us to overcome challenges, and bring us back to our authentic selves.Instagram: https://www.instagram.com/kellygores/Web: https://www.healwithkelly.co/about.htmlTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

Is our time quickly becoming the era of “psychedelic McCarthyism”? If we're not careful, that's where it looks like we're heading… In this episode of The Psychedelic Report, Dr. Dave Rabin sits down with Hamilton Morris for an in-depth discussion on the recent controversy surrounding MDMA-assisted therapy and the FDA's pivotal August 9th decision. Together, they address the backlash against MAPS/Lykos and how misinformation has fueled public skepticism and prevented this safe and powerful treatment from getting to millions of patients suffering from PTSD. Hamilton shares his experience from evaluation and investigation of the MDMA clinical trials and sheds light on the media's tendency to sensationalize allegations, including claims of misconduct during the trials. Hamilton and Dr Rabin emphasize the importance of relying on the scientific method, evidence-based data, and research, rather than sensationalized narratives, when assessing the safety and efficacy of MDMA-assisted therapy.The conversation also explores the broader implications of the FDA's ruling and how the negative hype surrounding psychedelics has overshadowed their significant therapeutic benefits and is causing harm to patients in need. They call for a more balanced and responsible approach to discussing these therapies in both journalism and public discourse, advocating for truth and evidence over fear and speculation. This episode offers critical insights into the challenges facing psychedelic research today, highlighting the need for thoughtful engagement with the ongoing developments in this field.Instagram: https://www.instagram.com/hamiltonmorris/Hamilton's Pharmacopeia: https://www.vicetv.com/en_us/show/hamiltons-pharmacopeiaThe Hamilton Morris Podcast: https://hamiltonmorris.buzzsprout.com/1870388Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

In this episode, Dr. Dave Rabin and Dr. Jonathan Edwards tackle the controversial topic of ketamine in light of the tragic death of actor Matthew Perry. Together, they explore the safety profile of ketamine, its legitimate uses in treating depression and suicidal ideation, and dispel misinformation regarding its association with Perry's passing.Dr. Edwards, a leading expert in ketamine-assisted therapy and author of The Revolutionary Ketamine, offers his insights on the pressing need for effective mental health treatments. As suicide rates continue to rise, particularly among young people, this episode emphasizes the potential of ketamine as a life-saving treatment and the importance of therapy in conjunction with medication.Tune in to gain a deeper understanding of ketamine's role in mental health and how it can potentially save lives.The Revolutionary Ketamine on AmazonStopping Pain: A Revolutionary Approach on AmazonDr. Jonathan Edwards' WebsiteSubscribe to Dr. Edwards' SubstackWeb: https://psychedelic.support/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

How do we optimize our bodies and our brains for learning new things? In this episode of The Psychedelic Report, Dr. Dave Rabin welcomes back nutritional biochemist Shawn Wells to explore the often-overlooked topic of post-psychedelic supplementation. They discuss how to optimize the benefits of psychedelic experiences and ensure that the transformations achieved during these journeys can last longer. Shawn shares his expertise on various supplements, nutrients, and dietary strategies that can enhance neuroplasticity, support mental health, and promote overall well-being after a psychedelic experience. The conversation covers essential topics such as hydration, the role of adaptogens, the importance of neurotransmitter repletion, and the impact of diet on recovery.Tune in for valuable insights from leading experts in the field of Psychedelic Medicine.Optimizing Psychedelic Medicine Experiences with Shawn WellsWeb: https://shawnwells.com/Instagram: https://www.instagram.com/shawnwellsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this episode, Dr. Dave Rabin discusses the impact of the FDA's decision, the potential delays in accessing this crucial treatment, and the unethical behavior of certain organizations influencing the FDA. Dr. Rabin is joined by Jon Lubecky, a retired army sergeant and Veteran who took part in MAPS MDMA therapy trials, as he discusses the implications of this rejection and emphasizes the need for ongoing advocacy and hope for eventual approval. The episode also addresses the unethical behavior of Symposia, an organization accused of falsifying information to the FDA to obstruct MDMA therapy approval. Additionally, former Symposia member David Nichols reveals serious ethical violations within the organization, raising questions about their motives and funding. Through these discussions, the episode highlights the critical need for transparency, ethical practices, and continued efforts to ensure access to psychedelic treatments for those in need.Rachel Nuwer's Scientific American Article: https://www.scientificamerican.com/article/fdas-rejection-of-mdma-psychotherapy-for-trauma-draws-criticism-from/Jon Lubecky's Conversation with David Nickles on Breaking Points: https://www.youtube.com/watch?v=lttFB0c0cAoWeb: https://psychedelic.support/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193

In this episode, Dr. Dave Rabin is joined by Dr. John J. Miller, a renowned clinical psychopharmacologist, to discuss the significance of the upcoming FDA decision on MDMA therapy for PTSD.John J. Miller, M.D. is Medical Director at Brain Health in Exeter, New Hampshire and has served as the Editor-in-Chief for Psychiatric Times since February 2019. He has worked for 38 years as a clinical psychopharmacologist, most recently 17 years as a Staff Psychiatrist at Seacoast Mental Health Center in Exeter, NH. Dr. Miller completed his B.S. in Biochemistry at the University of MA/Amherst. And medical school  and residency in Adult Psychiatry at the University of MA Medical School/Worcester. He is a Diplomate of the American Board of Psychiatry and Neurology. Since 1998 he has presented more than 3,000 lectures throughout the US on a wide range of psychiatric topics including PTSD. You can find Dr. Miller in his monthly editorials for Psychiatric Times that he has been authoring since March 2019.Discover the history of PTSD treatment, the current limitations of existing medications, and the promising results of MDMA-assisted therapy trials. Learn about the bipartisan support from lawmakers and the urgent need for FDA approval to provide relief to millions suffering from PTSD.Don't miss this insightful conversation on the potential paradigm shift in mental health treatment. Stay informed and advocate for change by tuning in to The Psychedelic Report.Brain Health in Exeter, New Hampshire (http://www.brain-health.co)Psychiatric Times (http://www.psychiatrictimes.com)https://x.com/PsychTimes?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthorhttps://www.linkedin.com/in/jjmillermd/https://www.linkedin.com/company/psychiatric-times/www.apolloneuro.comFDA petition for MDMA-assisted therapyhttps://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/

In this episode, Dr. Dave Rabin MD, PhD is joined by Dr. Geoff Bathje PhD who authored an article published on July 19, 2024 in Chacruna entitled: “The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy.”Dr. Bathje and Dr. Rabin discuss the recent FDA Advisory Committee vote on MDMA-assisted therapy for PTSD, which surprisingly and wrongfully concluded that the benefits do not outweigh the risks. This conversation deep dives into Dr. Bathje's report on how Psymposia, what appears to be a group of fringe radicals, negatively biased the FDA committee's vote on June 4 by writing letters with false and misleading claims in an attempt to prevent the clearance of MDMA for PTSD. Why would anyone not only want to prevent clearance of MDMA therapy for Veterans, but see themselves as heroes for doing so? Find out all that and more in this weeks episode of The Psychedelic Report.The Unbelievable Claims of Psymposia about MAPS and MDMA-Assisted Therapy by Dr. Geoff Bathje: https://chacruna.net/unbelievable-claims-of-psymposia-about-maps-and-mdma-assisted-therapy/Web: https://psychedelic.support/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/FDA petition for MDMA-assisted therapy https://healingmaps.com/sign-the-petition-to-approve-mdma-therapy/Food and Drug Administration5630 Fishers LaneRm. 1061Rockville, MD 20852Docket No. FDA-2024-N-193

In this episode of The Psychedelic Report, Jesse Gould, Veteran Army Ranger and Founder of the Heroic Hearts Project, joins Dr. Dave Rabin to explore the implications of the recent FDA advisory committee vote on MDMA-assisted therapy for Veterans with PTSD. They highlight concerns over the influence of non-objective groups on the committee's decision and discuss the potential impact on millions of individuals seeking effective treatment for mental health challenges.Join the conversation as they explore the implications of disrupting the progress of a groundbreaking treatment and the importance of advocating for evidence-based therapies. Learn how you can get involved and make your voice heard to support the advancement of MDMA-assisted therapy for those who need it most.To take action and stay informed, visit Heroic Hearts and sign up for updates on upcoming initiatives. Let's come together to ensure access to life-changing treatments for Veterans and individuals suffering from PTSD.Don't miss this insightful discussion on the intersection of medicine, advocacy, and the future of psychedelic therapies. Subscribe to The Psychedelic Report for more thought-provoking episodes on the latest developments in psychedelic medicine and healing.Web: https://heroicheartsproject.org/our-story/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this compelling episode of The Psychedelic Report, Dr. Dave Rabin delves into the evolving landscape of psychedelic-assisted therapies with special guest Jon Lubecki, a veteran and prominent advocate for such treatments in Ukraine. The discussion centers on the recent FDA advisory committee setback, which resulted in a 10 to 1 vote against MDMA-assisted therapy due to lingering concerns about its safety and efficacy, particularly in post-treatment activities like driving. Jon provides a nuanced analysis of the hearing, pointing out significant conflicts of interest among some opponents who failed to disclose their affiliations with competing therapies like psilocybin and ketamine. He also examines the critical role of influential organizations such as ICER and Symposia, whose biased reports have swayed public and regulatory opinions against MDMA trials. With a fervent focus on the broader implications for mental health, especially for veterans suffering from PTSD, Jon underscores the inadequacy of current treatments and the transformative potential of MDMA-assisted therapy. He shares his personal journey from struggling with PTSD to becoming a leading advocate, passionately calling for the democratization of access to these promising therapies, transcending political and social boundaries.Instagram: https://www.instagram.com/jonathanlubecky/Web: www.mdmaptsd.orgTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.comCongressman Dan Crenshaw speaks out on the MDMA-assisted therapy controversy and the anti-Veteran agenda : https://www.instagram.com/reel/C8zsu2Wu7M0/?utm_source=ig_web_copy_link&igsh=MzRlODBiNWFlZA==

Join Dr. Dave Rabin in this enlightening episode of The Psychedelic Report as he delves into the transformative journey of Tucker Max through psychedelic medicines. Tucker Max, a renowned author and entrepreneur, shares his personal experiences with MDMA, LSD, and ketamine-assisted therapy, revealing profound insights and healing moments.In this episode, Tucker discusses the importance of integration practices in maximizing the benefits of psychedelic experiences. He emphasizes the role of journaling, therapy, and lifestyle changes in supporting the integration process and facilitating personal growth. Tucker's journey highlights the profound impact of psychedelics on mental health, self-discovery, and relationships.Don't miss this insightful episode, where real-life experiences and expert perspectives converge to explore the healing potential of psychedelic medicines. Tune in now to embark on a journey of self-discovery and transformation with Tucker Max.Web: https://www.tuckermax.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.comTucker's Books: https://www.tuckermax.com/books/#:~:text=Tucker%20Max's%20first%20three%20books,success%20has%20meant%20his%20success.Rachel Nuwer's Breaking News on MDMA Phase 3 Trials Results in the NYT: https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.html

 In this compelling episode of The Psychedelic Report, Dr. Dave Rabin is joined by esteemed journalist Rachel Nuwer, renowned for breaking the pivotal story on the Phase 3 MDMA-assisted therapy trials for PTSD in The New York Times. Together, they delve into the recent contentious votes from the FDA Pharmacologic Advisory Committee, which advised against approving MDMA-assisted therapy despite robust evidence from clinical trials. Rachel provides an insider's perspective on the committee's decision, expressing disappointment over the unreasonably high standards applied to MDMA-assisted therapy compared to other psychiatric medications. She and Dr. Rabin discuss the committee's focus on issues like demographic representation and the integration of therapy with MDMA treatment, arguing that these criticisms overlook the proven benefits of MDMA in enhancing psychotherapy outcomes.The episode highlights the need for better education on psychedelic therapy within the medical community and critiques the media's role in spreading public misconceptions. Rachel and Dr. Rabin emphasize the potential of MDMA-assisted therapy to revolutionize PTSD treatment, especially for Veterans and other underserved populations. Despite the setback, they remain hopeful that the scientific evidence and patients' needs will ultimately prevail.Overall, the conversation underscores the importance of accurate reporting and increased awareness to advance psychedelic therapies and build public trust in these innovative treatments.Your Brain Explained - Can We Cute Mental Illness? The MDMA StoryApple: https://podcasts.apple.com/us/podcast/your-brain-explained/id1693658383?i=1000617879818Spotify: https://open.spotify.com/episode/4k4KWRzmn8o8N2Aer4MYAG?si=fd8c315823854dadRachel Nuwer's Breaking News on MDMA Phase 3 Trials Results in the NYT: https://www.nytimes.com/2023/09/14/health/mdma-ptsd-psychedelics.htmlRachel Nuwer's book I Feel Love: MDMA and the Quest for Connection in a Fractured World https://www.goodreads.com/book/show/62039306-i-feel-loveTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this episode of The Psychedelic Report, Dr. Dave Rabin explores the nexus of nutrition, supplementation, and optimizing psychedelic medicine experiences with Shawn Wells, an expert in diet, nutrition, and biochemistry. Shawn discusses the transformative impact of psychedelics on his life and emphasizes the importance of practices like fasting and dietary restriction to establish an optimal physiological baseline for meaningful journeys. They discuss how fasting can induce a ketogenic state, potentially enhancing neuroplasticity during psychedelic experiences. This conversation emphasizes the significance of preparation, both physically and mentally, for psychedelic experiences, highlighting the importance of adaptability, stress tolerance, and learning. Web: https://shawnwells.com/Instagram: https://www.instagram.com/shawnwellsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

In this episode of The Psychedelic Report, Dr. Dave Rabin and Dr. Amy Killen delve into the profound correlation between sexuality, intimacy, and longevity. Dr. Killen, a physician, presents compelling research demonstrating that regular sexual activity is associated with reduced mortality rates, particularly in men, attributing this effect to the physiological impact of sexual experiences, including the release of neurotransmitters like dopamine, endorphins, serotonin, and oxytocin. They advocate for a comprehensive approach to sexual education, emphasizing self-exploration, effective communication, and the destigmatization of pleasure. This episode addresses societal taboos around sexuality and underscores the importance of prioritizing sexual health in healthcare practices. Overall, they challenge listeners to adopt a more open-minded and holistic perspective on sexuality, recognizing its profound impact on overall well-being and quality of life.Web: https://dramykillen.com/Instagram:https://www.instagram.com/dr.amybkillen/Facebook: https://www.facebook.com/DrAmyBKillen/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

How can individuals improve their understanding of their capabilities and potential, particularly in the context of stress management and mindfulness practices?In this episode, Dr. Dave Rabin interviews Jeff Krasno, founder of Commune and a prominent figure in the health and wellness community, joins the discussion on stress, delineating between chronic distress and beneficial stress rooted in evolutionary pressures. Through Jeff's curated protocols, including intermittent fasting, cold therapy, and social experiments, listeners gain insight into harnessing the power of good stress to enhance physiological and psychological health. The conversation delves into the physiological benefits of good stress, the importance of optimal stress dosage, and the parallel between building psychological resilience and strengthening the immune system. Jeff emphasizes the role of attention control in shaping reality and advocates for meditation and mindfulness practices to cultivate it. The episode concludes with a reflection on embracing discomfort and life's uncertainties, including death, as avenues for growth and self-discovery through meditation and psychedelic exploration. Listeners can find Jeff Krasno on the Commune podcast and Instagram, with his course on good stress available on Commune's website, reflecting his mission to democratize access to transformative practices. Web: https://www.jeffkrasno.com/commune-podcastInstagram: https://www.instagram.com/jeffkrasno/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

How can we improve our self-awareness and enter altered states of consciousness to live more fully? Join Dr. Dave Rabin and Dave Asprey as they delve into a fascinating discussion on various methods for accessing altered states of consciousness and enhancing self-awareness. They explore practices such as breathwork, neurofeedback, psychedelics, tantra, and conscious kink, among others, emphasizing the diverse range of tools available for personal growth and transformation.Dave Asprey shares profound insights into the process of resetting trauma and the importance of gratitude and forgiveness in healing. He explains that forgiveness is not about condoning the actions of others but about releasing reactivity and cultivating inner peace. Gratitude, often overlooked in therapeutic practices, is highlighted as a crucial step towards self-trust and personal growth.This episode addresses common concerns about personal transformation and reassures listeners that growth and change are natural processes that can lead to greater happiness and fulfillment.Web: https://40yearsofzen.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

What happens when we explore the intersection of psychedelic medicines and healing? In this episode, Dr. Dave Rabin and Dr. Jeff Chen embark on a journey through the landscape of psychedelic drugs, from their historical roots in America's counterculture to their re-examination for therapeutic purposes today. Delving into the challenges of conducting research on psychedelic substances, particularly under regulatory restrictions, they shed light on the potential of cannabis for psychedelic-assisted therapy. Join them as they discuss the evolving field of psychedelic research, touching on crowd-sourced studies, decriminalization, and the crucial integration of therapy with psychedelic experiences. This episode provides a comprehensive overview of the current state of psychedelic research, the challenges and opportunities in the field, and the potential for these substances to revolutionize mental health treatment. Join Dr. Dave Rabin and Dr. Jeff Chen as they navigate the complex and fascinating world of psychedelic medicines and healing.Web: https://radiclescience.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

Can psychedelics and sexuality transform healing? Can we access powerful psychedelic states through intimacy, connection, and sexual experiences? What happens when you combine psychedelic medicines and sex? In this special Valentines Day episode of The Psychedelic Report, Dr. Dave Rabin is joined by Jaiya, renowned expert in sexual healing and empowerment to explore the transformative power of psychedelic experiences and their potential to heal trauma, enhance sexual experiences, and much more! Jaiya shares her personal journey of healing and how she discovered the profound connection between sexuality, psychedelics, and trauma healing. They dive into the concept of trauma and its impact on the brain, as well as the importance of creating safety and consent in both psychedelic experiences and sexual encounters. This episode also touches on the role of intention in psychedelic and sexual experiences, the power of pleasure as a healing tool, and the need for a code of ethics in psychedelic use that includes the exploration of sexuality. Jaiya leaves us with the concept of the five erotic blueprints, providing insights into different types of sexual expression and how they can be integrated into healing and personal growth. If you've ever had questions about sexuality and intimacy and how to invite more of it into your life, this is the show for you!Web: https://theblueprintbreakthrough.com/book/Instagram: https://www.instagram.com/missjaiya/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

How do the ancient traditions shed light on the interplay between science, spirituality, and the transformative journey of self-discovery? In this episode, Dr. Dave Rabin and Katie Silcox explore the fascinating intersection of science and spirituality. Katie, with an extensive background in Hinduism and Ayurveda, shares her journey into the world of tantric and yogic traditions. They discuss how these traditions aim to expand the mind beyond our limitations, emphasizing practices like breathing for inner exploration. The conversation touches on how these practices actually change our bodies, including Kundalini awakening and the balance of inner feminine and masculine aspects. They also explore the importance of grounding, self-acceptance, and the rise of the divine feminine in modern spirituality. Overall, this episode continues our 2024 exploration into the intricate connections between science and spirituality, providing a holistic understanding of consciousness and the deep interplay between mind, body, and ancient wisdom.Web: https://theshaktischool.com/Instagram: https://www.instagram.com/theshaktischool/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/Web: www.ApolloNeuro.com

How do you define sobriety?This week's episode features an enlightening discussion with biohacking influencer and interviewer Luke Storey about his personal journey with addiction, recovery, and the mindful integration of plant medicines.Luke shares vulnerably about the childhood trauma that led him down a path of substance abuse, and how eventually hitting rock bottom inspired his sobriety 24 years ago.He explained his thoughtful process around redefining sobriety and abstinence as he began to explore the healing potential of psychedelics like ayahuasca.Luke and Dr. Dave Rabin have an insightful conversation about the difference between substances that disconnect us from consciousness versus those that can open portals to personal and spiritual growth.They explored the importance of set, setting, intention, and integration when working with plant medicines. Join us for this thought-provoking look at how psychedelic medicines, when used consciously, can catalyze awe, disrupt negative thought patterns, reveal deeper layers of healing, and may provide a glimmer of hope for addiction treatment in the 21st century.Web: https://www.lukestorey.com/Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

Join us for a thoughtful conversation between expert panelists in the fields of psychology, neuroscience, meditation, and psychedelics, recorded live at Open studio in Venice, California. Led by Apollo Neuro co-founder and Chief Medical Officer Dr. Dave Rabin, MD, PhD, with Manoj Dias, co-founder of Open, and Lauren Swanson, the Director of Patient Care at Wondermed Health, which provides ketamine treatment for anxiety and depression, they discuss where mindful practices like meditation and breathwork, psychedelic medicine, and wearable health overlap and where they differ, and how these practices can be used in tandem for healing and growth.Learn more about Apollo Neuro here.Download Open's mindfulness app here.Discover more about Wondermed here.

Is the field of psychedelic therapy receiving the educational support it needs? In this episode, Dr. Dave Rabin engages in a thought-provoking conversation with Dr. Allison Feduccia, a neuropharmacologist and the founder of Psychedelic Support. They explore the organization's mission, which includes providing crucial resources, a directory of licensed health professionals, and ACCME-accredited online courses covering substances like MDMA, psilocybin, and ketamine. The episode sheds light on the hurdles Psychedelic Support faces in obtaining ACCME accreditation for their courses, raising concerns about the impact on education accessibility. The dialogue encompasses the FDA's warning on ketamine treatments, its contradictory extension through telehealth by the DEA, and Dr. Allison Feduccia's personal journey with ayahuasca, leading to her involvement in equine facilitated services and the development of a course on equine therapy. As they discuss the potential changes in accreditation, Dr. Allison emphasizes the significance of clinicians taking these courses and supporting organizations like Psychedelic Support in advancing psychedelic therapy education.Web: https://psychedelic.support/ACCME Web:https://www.accme.org/https://www.instagram.com/accreditedcmeContact number: (312) 527-9200Twitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

Have you ever wondered about the real-world impact of microdosing psychedelics? In this episode, Dr. Dave Rabin interviews Dr. Pamela Kryskow and Dr. Zach Walsh, investigators on the Microdose.me study—one of the world's largest real-world studies on people microdosing psychedelics. Dr. Kryskow and Dr. Walsh discuss their backgrounds and entry into the psychedelic space, emphasizing the importance of observing real-world experiences. The Microdose.me study aims to provide substantial clinical data to support this promising new area of research. Their findings highlight positive outcomes for microdosers, including cognitive benefits for individuals over 55. The researchers stress the challenges of real-world studies, the need for collaboration, and the study's potential to guide future clinical trials.Web: Microdose.meTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

In this episode Dr. Dave Rabin had the privilege of speaking with the late Dr. Roland Griffiths, a renowned figure in the field of psychedelic science and medicine. Dr. Griffiths, who passed away on October 16, 2023, was a pioneer in the study of consciousness and the therapeutic potential of psychedelic medicines. Dr. Griffiths was the Director of the Center for Psychedelic and Consciousness Research at Johns Hopkins University School of Medicine, shares his journey into the field, driven by his interest in meditation and altered states of consciousness. His groundbreaking research on psilocybin, the active compound in magic mushrooms, is discussed, highlighting the profound effects it induces, including mystical experiences and psychological insights. Dr. Griffiths underscores the need for further research into the variations among different strains of psilocybin mushrooms and the future of psychedelic therapy, which may involve novel compounds and therapeutic approaches. This episode provides valuable insights into the potential of psilocybin mushrooms for depression treatment and the ongoing advancements in psychedelic medicine.Web: https://hopkinspsychedelic.org/griffithsTwitter: https://twitter.com/DrDavidRabinInstagram: https://www.instagram.com/drdavidrabinWeb: https://www.drdave.io/

What is the Mind-Body Connection? In this episode, Dr. Candace Lewis PhD guides us through the intriguing intersections of stress, trauma, epigenetics, and mental health. Beginning her research in an addiction lab, she explored early-life stress and its impact on addiction vulnerability. Her deepening interest in epigenetics led her to delve into how traumatic experiences can alter gene regulation in the brain, laying the foundation for her exploration of psychedelics and their potential for healing. Candice stresses the importance of distinguishing between drug classes, with a focus on the therapeutic potential of psychedelics that can induce positive behavioral changes. Her pivotal research includes a pilot study on MDMA-assisted therapy for PTSD, suggesting DNA methylation changes may contribute to treatment responses. The conversation extends to redefining trauma, the role of genetics and epigenetics in mental health, and the intriguing link between psychology, the brain, and the body. Candice also highlights ongoing studies on psychedelics, cognitive abilities and epigenetics, offering hope for cognitive decline prevention. Her lab initiatives encompass a social media drug education project and the Translational Research in Psychedelics (TRIP) team, both aimed at raising awareness and fostering informed discussions.https://TheBearLab.org/@the_bear_labYour Brain Explained

Have you ever wondered how you can make a difference in the betterment of mental health care for all? In this episode, Dr. Dave Rabin gets the latest updates from Dr. Jeanne Fontana MD, PhD about the Treat California campaign, a citizen-driven ballot initiative to revolutionize the way we deliver mental healthcare in the US by allocating over $5 billion to improving research, training, and safe access to psychedelic therapies. Today, we call on all Californians to show that you care about solving the crisis of mental illness up by donating $10, signing a petition, and educating others to do the same. Dr. Fontana's dream is to make these life-changing medicines accessible to every American and her team is well on the way! Dr. Fontana also reminds us of the importance of patience and compassion as we strive for better mental health care. Could this campaign be as game-changing as supporting the discovery of antibiotics were for infections? Tune in to find out and learn how you can play a critical role in making high quality mental health care available for all by joining the TreatCalifornia movement.www.TreatCalifornia.orghttps://voterstatus.sos.ca.gov/https://registertovote.ca.gov/@treatcalifornia

Can investing in psychedelics pave the way for a more conscious and compassionate approach to mental health and wellness? Dr. David Rabin engages in an illuminating conversation with Ozan Polat and Ryan Zurrer, a trailblazing venture capitalist redefining investment paradigms in the psychedelic space. Ryan introduces the concept of regenerative financing, sharing an innovative hybrid model that combines equity and debt for organizations like MAPS, fostering conscious health and sustainable investments. This episode delves into the balance between impact and profit, emphasizing the importance of cultural respect and responsible capital deployment. The trio dig into the imperative of respectful engagement with indigenous traditions and knowledge, highlighting the need for sustainable and non-extractive collaboration, the promising trajectory of psychedelic therapies, their increasing accessibility, and the potential to revolutionize mental health. Excitement resonates as they envision a future where acceptance of these therapies is widespread, even among generations who have been skeptical. Gratitude permeates as they reflect on the significance of building awareness and a strong scientific foundation for this transformative industry.https://www.vine.vc/

What if ancient medicines held the key to profound healing and transformation? In this enlightening episode of "The Psychedelic Report," Dr. Dave Rabin engages in a captivating conversation with Dr. Joseph Barsuglia, an esteemed clinical psychologist and MAPS-trained MDMA-assisted psychotherapist. Together, they delve into the depths of Iboga and 5MEO-DMT – two potent substances with rich histories and remarkable potentials. Explore the cultural heritage of Iboga in the Bwiti tradition, its therapeutic applications, and the delicate balance of its conservation. Uncover the mysteries of 5MEO-DMT, its unique effects, and the necessity of proper guidance. Join them in unraveling the transformative power of these ancient medicines and the responsible paths to harnessing their benefits within the realms of spirituality and therapy.

Have you ever heard of a headache so agonizing that it's been nicknamed the "suicide headache"? Imagine experiencing excruciating pain, primarily on one side of your head, accompanied by tearing, nasal congestion, and drooping eyelids. Now, imagine enduring this torment multiple times a day, each episode lasting anywhere from 15 minutes to several hours. It's not just a nightmare scenario; it's a reality for those who suffer from cluster headaches. Join Dr. Dave Rabin MD, PhD as he sits down with Dr. Emmanuelle Schindler MD, PhD, a physician-scientist from Yale University, to take us on a journey to explore the fascinating potential of psilocybin as a promising solution that might seem surprising, but it actually works for many sufferers of this extremely challenging disorder. Help is on the way!

What's with the war on drugs? Are we setting an impossibly high standard for psychedelic medicine? Does law enforcement truly understand the psychedelic approach, or are they enforcing laws based on past misconceptions. Join me as I sit down with psychedelic detective Hamilton Morris of Hamilton's Pharmacopeia on VICE to explore the major issues and aspirations of the psychedelic frontier. Discover why psychedelics remain illegal, and how their potential to dissolve societal norms challenges the status quo. Tune in to this mind-expanding episode of The Psychedelic Report as we venture into the uncharted realms of psychedelic medicine.

Have you ever wondered where some of our society's most popular music came from? What experiences inspired the song writing of our most beloved tunes? Well you may have guessed right... It's psychedelics of course! From cannabis to psilocybin mushrooms, use of drugs has long influenced the way we communicate through song. In this groundbreaking episode, I sit down with Leila Steinberg, the renowned poet, educator and visionary who discovered Tupac Shakur, to explore the profound impact of psychedelics on music to elevate consciousness, ignite social change, and inspire true artistry. You won't want to miss this first glimpse into the world behind Tupac's music and how his use of psychedelics, discussed for the first time in this interview, fueled the hip-hop revolution that changed the world forever.

Have you ever wondered when and where the use of psychedelic substances began? What is the history of the use of these powerful consciousness altering tools in western religions like Christianity? We'll answer these questions and more with New York Times best-selling author of The Immortality Key, Brian Muraresku on The Psychedelic Report. If you've ever asked the questions, "what is the meaning of life?" or "what is the Holy Grail?", you won't want to miss this because we've got the answers! And we'll launch into the origins of the western religious and spiritual use of psychedelic medicines, how this shaped our culture, and how psychedelic states will continue to influence our transition into the next phase of humanity.

Curious about how our society can thoughtfully integrate the advancements in psychedelic research and medicine? Wondering what the future of the psychedelic renaissance will look like? Inspired by Tim Ferriss and Psychedelic Science 2023, our guests Dr. Rachel Yehuda, Graham Boyd, and Jamie Wheal share a conversation that sheds light on the immense potential of these transformative therapies, while emphasizing the critical importance of re-centering ourselves around the mission so we can plan for the future. You will be on the edge for seat for this enlightening discussion into psychedelic medicines, patents, and funding new psychedelic developments on The Psychedelic Report. Gain a fresh perspective on the future of mental health, the profound impact of psychedelics, and the important work done by Rick Doblin and MAPS from some of the world's leading psychedelic minds.

Ever thought about how investing in psychedelics could shape the future of medicine and therapy? Are you ready to explore how this movement can drive social change and foster a new era for mental health? Join me and special guests, Sa'ad Shah and Warren Wright, the founders of the Noetic Fund, as we dive into the world of psychedelic investment and how to be smart about deploying capital in this space. Discover how we can challenge the existing narrative and drive positive change in mental healthcare.

Are you curious about the potential of psychedelic medicine for treating addiction? Wanna learn how to cultivate a sense of wonder and appreciation for the miraculous beauty of that is life? In this week's episode of The Psychedelic Report, I am joined by Mike "Zappy" Zapolin, a renowned futurist, psychedelic concierge to the stars, and award-winning filmmaker to discuss psychedelic therapy, healing from addiction, and much more. Discover how to cultivate wonder and appreciation for the world around us, even in the darkest times.

Have you ever wondered if psychedelic experiences are safe or how to make them safer? How can we support each other better to get through challenging situations? We'll discuss all this and more with Hanifa Washington and Joshua White, leaders of Fireside Project, the psychedelic peer-support hotline. We'll explore the healing power of community and the beauty of being present to listen to someone else while they navigate unknown territory under the hood of their consciousness car. Discover how Fireside Project is revolutionizing peer support and creating safe space for navigating and unpacking psychedelic journeys by checking out their website (https://firesideproject.org) or calling 62-FIRESIDE. Tune in to this episode of The Psychedelic Report to invite more community, empathic listening, and self-compassion into your life.

Can understanding recovery, grieving, and psychedelics expand our ability to heal from burnout and trauma? What can psychedelics teach us about the future of consciousness and how to overcome challenging situations? In the latest episode of @thepsychedelic.report, join me and @SherryWalling, PhD as we dive into the world of MDMA-assisted therapy and the power of grief to help us heal. Discover the power of transformative tools and the hard reset they can offer us.

Have you ever wondered if you're allowed to fully express yourself, including all your emotions? How do we tap into our innate ability to heal ourselves? As caregivers, we devote our lives to helping others heal, with little left for ourselves. With more caregivers facing burnout than ever, it couldn't be more important to support one another and make healing fun again! Join me and Lauren Taus, on this week's episode of The Psychedelic Report, as we discuss the importance of both psychedelic and somatic therapies and how having courage to attempt the skill of grieving can take our healing to the next level.

Have you ever wondered how psychedelic medicines like ketamine work on the brain to change the way we think, feel, and heal? If so, this is your opportunity to dive into understanding what we know about how these powerful tools work as some of the most meaningful therapeutic tools we have had in the history of our field to treat disorders like depression and PTSD. Join me and Dr. Jeffrey Becker MD, a leading expert in the field of ketamine medicine and mechanism for a thrilling conversation on states of psychedelic transcendence that promote healing from some of the most challenging cases of mental illness and what we can learn from neuroscience to help us continue to grow.

What challenges do psychedelic researchers face in securing funding? How can you get involved to help make a difference? Join me and Dr. Jeannie Fontana MD, PhD on The Psychedelic Report as we explore Dr. Fontana's pioneering work to support stem cell therapies in California and what we can learn about how to successfully fund psychedelic research for years to come.

Have you ever wondered about microdosing psychedelic medicines? What is microdosing and why is it all the rage right now? How do psychedelics used in therapy help us access our full potential by accepting all of our selves? On this episode of The Psychedelic Report, we'll discuss all this and more with Dr. James Fadiman and Jordan Gruber, two leading experts on psychedelic psychotherapy and microdosing.

Do you know the current medicinal uses of cannabis and psychedelics? Have you heard the recent federal policy updates regarding cannabis?

Have you ever wondered why it's so hard to change old habits? Does it seem like the tools we're given to make change don't get us over the hump most of the time? Can psychedelic therapy accompanied by psilocybin or ketamine help us make behavior change easier and longer lasting? We'll answer these questions and much more with world-renowned psychedelic medicine and addiction researcher, Dr. Matt Johnson PhD, The Susan Hill Ward Endowed Professor of Psychedelics and Consciousness Research at Johns Hopkins. Working with psychedelics for 17 years, he is one of the world's most widely published experts in the field. He has published research on psychedelics and mystical experiences, personality change, tobacco smoking cessation, cancer distress treatment, and depression treatment. He's been Interviewed by Anderson Cooper on 60 Minutes, the New York Times, the Washington Post, the Wall Street Journal, the BBC and was featured in Michael Pollan's book How to Change Your Mind. Tune in, turn on, and immerse yourself in this wild conversation on everything you need to know to begin to change your life!

Have you ever wondered about microdosing, psilocybin, or mushrooms?

What is burnout? How can we care for ourselves to sustain peak performance for the long haul? Can ketamine therapy help? We'll dive into all these questions and more with Dr. Phil Wolfson, physician, psychedelic psychotherapy pioneer, and founder of Ketamine Assisted Psychotherapy (KAP) in episode 4 of The Psychedelic Report. Dr. Wolfson is also the author of The Ketamine Papers and founder of the Ketamine Research Foundation. Join us for a rare look into the history of psychedelic experiences and modern psychedelic medicines followed by a launch into human consciousness to build a worldwide culture of love, sharing, tolerance and freedom for all. 

Can science help us figure out how psychedelic medicines work? What are the important differences between legalization of psychedelic medicines and decrim? Episode 3 of The Psychedelic Report dives into all this and more with Senior Correspondent Jonathan Lubecky and the brilliant Dr. Rachel Yehuda PhD, Endowed Professor of Psychiatry and the Neurobiology of Trauma, and Director of the Center for Psychedelic Psychotherapy and Trauma Research Icahn School of Medicine, Mount Sinai. Authoring more than 500 published papers, chapters and books in the field of traumatic stress and the neurobiology of PTSD, Dr. Yehuda shares her vast knowledge and experience with us while discussing the fascinating topics of epigenetics and neurogenesis. And don't miss the special appearances at the end by author Jamie Wheal and Alexander Beiner, director of Breaking Convention. Strap your Apollo on... we're going in!Strap your Apollo on... we're going in!

Is it possible to learn how to push the boundaries of our minds and bodies with technology? Is medicine really required to access non-ordinary states of consciousness? We'll explore all this and more with special guests Amy Stanton, founder of Stanton & Co., and Ariel Garten, co-founder of Muse, on episode 2 of The Psychedelic Report

Is it possible to uplift global consciousness in one generation? Explore how we can take control over our lives, our consciousness, and what we can learn from psychedelic states with Jamie Wheal, acclaimed speaker and author of Recapture the Rapture: Rethinking God, Sex and Death In a World That's Lost Its Mind, and the Pulitzer prize nominated global bestseller Stealing Fire. In this first episode of The Psychedelic Report, I am coming to you from the G20 Global Summit in Bali, Indonesia as one of the delegates educating the developing world on psychedelic medicines and wearables. Tune in for an enchanting and eye opening conversation about psychedelic states, what they mean, what the developing world thinks about all this, and we'll leave you with a guide for where to go from here.